var title_f6_35_6704="Masto cutaneous infant";
var content_f6_35_6704=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F61345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F61345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital cutaneous mastocytosis in an infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Disseminated brown-red plaques spread over the whole body, including the face but no mucosal region. Events of flushes with bronchoconstriction were triggered by heat and breast-feeding.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mann, C, Sepp, N, Simma, B. Congenital cutaneous mastocytosis. J Pediatr 2004; 145:134. Copyright &copy;2004 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6704=[""].join("\n");
var outline_f6_35_6704=null;
var title_f6_35_6705="Temocapril: International drug information";
var content_f6_35_6705=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"9\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Temocapril: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4302648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acecol (JP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F3335280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Temocapril Hydrochloride",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F3335281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Angiotensin-Converting Enzyme (ACE) Inhibitor",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F3335282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypertension",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F3335284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: Initial: 1 mg/day; maintenance: 2-4 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821153\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F3335285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 1 mg, 2 mg, 4 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10506 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.247-661AF214C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6705=[""].join("\n");
var outline_f6_35_6705=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4302648\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3335280\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3335281\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3335282\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3335284\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821153\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3335285\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10506\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10506|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_35_6706="Ciprofloxacin and hydrocortisone: Pediatric drug information";
var content_f6_35_6706=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ciprofloxacin and hydrocortisone: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35826?source=see_link\">",
"    see \"Ciprofloxacin and hydrocortisone: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?1/26/1444?source=see_link\">",
"    see \"Ciprofloxacin and hydrocortisone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F151824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cipro&reg; HC",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F151825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cipro&reg; HC",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1046334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic/Corticosteroid, Otic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1046332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35826?source=see_link\">",
"      see \"Ciprofloxacin and hydrocortisone: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;1 year and Adults: Otic: Instill 3 drops into the affected ear(s) twice daily for 7 days",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F151817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Suspension, otic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cipro&reg; HC: Ciprofloxacin hydrochloride 0.2% and hydrocortisone 1% (10 mL) [contains benzyl alcohol]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F151809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1046338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Otic: Warm suspension by holding bottle in hand prior to instillation; shake well before use; patient should lie with affected ear upward and maintain position for 30-60 seconds after suspension is instilled into the ear canal",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1046337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of acute bacterial otitis externa due to susceptible strains of",
"     <i>",
"      S. aureus",
"     </i>",
"     ,",
"     <i>",
"      P. aeruginosa",
"     </i>",
"     , or",
"     <i>",
"      Proteus mirabilis",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F13881574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening: Alopecia, fungal dermatitis, hypersensitivity reactions, migraine, paresthesia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1046340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ciprofloxacin, hydrocortisone, any component, or other quinolones; patients with perforated tympanic membrane; patients with viral infections of the external ear canal",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F151832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F151814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9624500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14287198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted with this combination. Refer to individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13158 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-CA557B663F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6706=[""].join("\n");
var outline_f6_35_6706=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151824\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151825\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046334\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046332\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151817\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151809\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046338\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046337\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13881574\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046340\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151832\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151814\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9624500\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14287198\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13158\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13158|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35826?source=related_link\">",
"      Ciprofloxacin and hydrocortisone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/26/1444?source=related_link\">",
"      Ciprofloxacin and hydrocortisone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_35_6707="Acetylcholine: Drug information";
var content_f6_35_6707=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acetylcholine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/57/17299?source=see_link\">",
"    see \"Acetylcholine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/5/27730?source=see_link\">",
"    see \"Acetylcholine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Miochol&reg;-E",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F130091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Miochol&reg;-E",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F130115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Cholinergic Agonist;",
"     </li>",
"     <li>",
"      Ophthalmic Agent, Miotic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F130094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     To produce miosis: Intraocular: 0.5-2 mL of 1% injection (5-20 mg) instilled into anterior chamber before or after securing one or more sutures",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F130095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15671278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15671279\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F130075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for solution, intraocular, as chloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miochol&reg;-E: 20 mg (2 mL) [supplied with diluent; reconstitution results in 1:100 solution]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F130061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F130078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmic: Open under aseptic conditions only. Attach filter before irrigating eye. Instill into anterior chamber before or after securing one or more sutures; instillation should be gentle and parallel to the iris face and tangential to the pupil border; in cataract surgery, acetylcholine should be used only after delivery of the lens.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F130076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Produces complete miosis in cataract surgery, keratoplasty, iridectomy, and other anterior segment surgery where rapid miosis is required",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F130123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Acetylcholine may be confused with acetylcysteine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F130113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, flushing, hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Clouding, corneal edema, decompensation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F130081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to acetylcholine chloride or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F130065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diseases affected by systemic effects: Systemic effects rarely occur but can cause problems for patients with asthma, GI spasm, acute heart failure, hyperthyroidism, Parkinson's disease, peptic ulcer disease, and or urinary tract obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Aseptic conditions: Open under aseptic conditions only; do not gas sterilize.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cataract surgery: During cataract surgery, use only after lens is in place.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F130070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: May enhance the adverse/toxic effect of Cholinergic Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction. Management: Administer these agents in combination with caution, and monitor for conduction disturbances.  Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322963\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Miochol-E Intraocular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (1): $72.97",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acetilcolina Colirio (AR);",
"     </li>",
"     <li>",
"      Acetilcolina Cusi (ES);",
"     </li>",
"     <li>",
"      Miochol (FI, LU, NL, PT);",
"     </li>",
"     <li>",
"      Miochol-E (AU, BE, CH, CN, DE, DK, FI, GB, GR, HK, ID, IE, IL, IT, KP, NL, NO, NZ, SE, SG, TR, ZA);",
"     </li>",
"     <li>",
"      Miochole (FR);",
"     </li>",
"     <li>",
"      OQ-Miot (CO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F130064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Causes contraction of the sphincter muscles of the iris, resulting in miosis and contraction of the ciliary muscle, leading to accommodation spasm",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F130080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: ~6 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Roszkowska AM, Ferreri G, Squeri CA, et al, \"Effect of Intraocular Acetylcholine and Carbachol on the Corneal Endothelium.",
"      <i>",
"       In vivo",
"      </i>",
"      Comparative Study,\"",
"      <i>",
"       Ophthalmologica",
"      </i>",
"      , 1998, 212(6):407-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/35/6707/abstract-text/9787232/pubmed\" id=\"9787232\" target=\"_blank\">",
"        9787232",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9303 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-4563C940AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6707=[""].join("\n");
var outline_f6_35_6707=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130090\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130091\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130115\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130094\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130095\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671278\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671279\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130075\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130061\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130078\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130076\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130123\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130113\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130081\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130065\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298676\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130070\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322963\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038317\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130064\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130080\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9303\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9303|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/57/17299?source=related_link\">",
"      Acetylcholine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/5/27730?source=related_link\">",
"      Acetylcholine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_35_6708="Cholesterol crystal";
var content_f6_35_6708=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F85633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F85633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Cholesterol crystals in synovial fluid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 462px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cholesterol crystals from a chronic joint effusion aspirated from a patient with rheumatoid arthritis are shown on examination of synovial fluid using color compensated polarized light microscopy.&nbsp; Note the notched shield-shaped cholesterol crystals.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of H Ralph Schumacher, MD, and Tim Jansen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6708=[""].join("\n");
var outline_f6_35_6708=null;
var title_f6_35_6709="Promethazine and dextromethorphan: Patient drug information";
var content_f6_35_6709=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Promethazine and dextromethorphan: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/58/18341?source=see_link\">",
"     see \"Promethazine and dextromethorphan: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10018082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before giving this drug to a child. Check all of your child's drugs, including OTC, with doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691646",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop coughing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700964",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give this drug to a child younger than 2 years of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701926",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dextromethorphan, promethazine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703713",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018088\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697679",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is not for coughs due to smoking or lung disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697320",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have Parkinson's disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness, trouble moving around, or stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11843 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-EFB8DDA1F5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6709=[""].join("\n");
var outline_f6_35_6709=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018082\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018084\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018083\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018088\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018089\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018091\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018086\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018087\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018092\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018093\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/58/18341?source=related_link\">",
"      Promethazine and dextromethorphan: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_35_6710="Transfusion-associated graft-versus-host disease";
var content_f6_35_6710=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Transfusion-associated graft-versus-host disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6710/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6710/contributors\">",
"     Arthur J Silvergleid, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6710/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6710/contributors\">",
"     Steven Kleinman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6710/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6710/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/35/6710/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Graft-versus-host disease (GVHD) is a rare, almost always fatal complication of a blood transfusion. It occurs much more commonly after hematopoietic cell transplant (HCT), a setting in which it is less severe &mdash; mortality rate of 20 to 25 percent following transplantation versus 80 to 90 percent when associated with a transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    GVHD results from an attack by viable immunocompetent donor lymphocytes on the recipient's antigen presenting tissues. This immunologic assault is manifested clinically by dysfunction of the skin, liver, gastrointestinal tract and bone marrow. The effect on the bone marrow distinguishes transfusion-associated GVHD (ta-GVHD) from transplantation-associated disease. With HCT, the bone marrow cells in the recipient are of donor origin and are therefore exempted from attack. Thus, bone marrow aplasia, which is the primary cause of death in ta-GVHD, is an infrequent complication after HCT [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS AND INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;GVHD does not occur after most transfusions because the donor lymphocytes are destroyed by the recipient's immune system before they can mount a response against the host. However, this protective response does not occur in two settings: when the recipient is immunodeficient; and when there is a specific type of partial HLA matching between the donor and recipient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Immunodeficient states",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transfusion-associated GVHD was first described in 1965 in a cohort of immunodeficient children [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/4\">",
"     4",
"    </a>",
"    ]. Over the next 15 years, 38 cases were reported in a number of different immunodeficient states, including newborns with erythroblastosis fetalis, Hodgkin's and non-Hodgkin lymphoma, and acute and chronic leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/5\">",
"     5",
"    </a>",
"    ]. Other patients at risk include those with solid tumors who are immunosuppressed because of chemotherapy (eg, purine analog therapy) or radiation and severe congenital or acquired immune deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By 1980, the incidence of ta-GVHD was estimated at 0.1 to 1.0 percent in patients with hematologic cancers or lymphoproliferative disorders. With the increased use of irradiation and leukoreduction of blood products in the 1990s, as well as a decreased use of fresh blood and directed donations, the incidence of ta-GVHD has fallen considerably. As an example, the incidence of ta-GVHD was approximately 0.15 percent in Japan between 1981 and 1986, whereas there were no cases reported in Japan during 2000 or 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One interesting observation for which there is as yet no explanation is that ta-GVHD has not been described in a patient with AIDS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Partial HLA matching",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1986, ta-GVHD was first described in a patient without obvious immunodeficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/9\">",
"     9",
"    </a>",
"    ]. This and subsequent reports established a second group of patients at risk for ta-GVHD: recipients of blood who are",
"    <strong>",
"     heterozygous",
"    </strong>",
"    for an HLA haplotype for which the donor is",
"    <strong>",
"     homozygous",
"    </strong>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/10\">",
"     10",
"    </a>",
"    ]. In this setting, the recipient does not recognize the donor lymphocytes as being foreign, since the only HLA antigens seen by the host lymphocytes are shared by the recipient. However, the reverse is not true, since the donor lymphocytes view the host's tissues as foreign, leading to immunologic activation and ta-GVHD.",
"   </p>",
"   <p>",
"    The incidence of ta-GVHD in immunocompetent recipients is not known, but may be related to genetic variability within a population, as well as the incidence of consanguineous marriage [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/11\">",
"     11",
"    </a>",
"    ]. It has been estimated that the frequency with which blood from an individual homozygous for an HLA haplotype is transfused into a recipient heterozygous for that haplotype is approximately one in 659 in Japan and varies from 1 in 500 to 1 in 7174 in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition, any patient receiving either HLA-matched blood components or blood from a blood-related relative should be considered at risk [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Implicated blood products",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ta-GVHD has been reported after the administration of nonirradiated whole blood, packed red cells, platelets, granulocytes, and fresh, non-frozen plasma. In comparison, ta-GVHD does not appear to be induced by frozen, deglycerolized red cells, fresh frozen plasma, or cryoprecipitate.",
"   </p>",
"   <p>",
"    Studies in animals suggest that approximately 10",
"    <sup>",
"     7",
"    </sup>",
"    lymphocytes per kg of recipient weight are required to produce disease in a susceptible host [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/13\">",
"     13",
"    </a>",
"    ]. The per unit lymphocyte content of the blood components that can induce ta-GVHD is [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Whole blood and red cells &mdash; 1-2 x 10",
"      <sup>",
"       9",
"      </sup>",
"     </li>",
"     <li>",
"      Platelet concentrates &mdash; 4 x 10",
"      <sup>",
"       7",
"      </sup>",
"     </li>",
"     <li>",
"      Apheresis platelets &mdash; 3 x 10",
"      <sup>",
"       8",
"      </sup>",
"     </li>",
"     <li>",
"      Washed or microaggregate-filtered red cells &mdash; 2.5 x 10",
"      <sup>",
"       8",
"      </sup>",
"     </li>",
"     <li>",
"      Granulocytes by apheresis &mdash; 5-10 x 10",
"      <sup>",
"       9",
"      </sup>",
"     </li>",
"     <li>",
"      Frozen, deglycerolized red cells &mdash; 5 x 10",
"      <sup>",
"       7",
"      </sup>",
"      , which is generally below the amount required to produce ta-GVHD in adults",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ta-GVHD develops 4 to 30 days after blood transfusion. Patients typically present with fever and an erythematous, maculopapular rash which often progresses to generalized erythroderma and, in extreme cases, to toxic epidermal necrolysis. Other symptoms include anorexia, vomiting, abdominal pain (most often in the right upper quadrant), profuse diarrhea (up to 7 to 8",
"    <span class=\"nowrap\">",
"     L/day),",
"    </span>",
"    and cough.",
"   </p>",
"   <p>",
"    The main laboratory findings are pancytopenia (which reflects a strikingly hypocellular marrow), abnormal liver function tests, and electrolyte abnormalities induced by diarrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of ta-GVHD is frequently delayed because the symptoms are relatively mild or are attributed to the underlying illness. The diagnosis is suggested from biopsy of affected skin, which classically reveals vacuolization of the basal layer and a histiocytic infiltrate, which is also seen in the aplastic bone marrow. Skin biopsy occasionally shows an almost pathognomonic finding &mdash; satellite dyskeratosis, which is characterized by single, dyskeratotic cells accompanied by lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/15\">",
"     15",
"    </a>",
"    ]. The definitive diagnosis can be established only if the circulating lymphocytes are shown to have a different HLA phenotype from host tissue cells, thereby proving that they came from the donor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TREATMENT AND PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ta-GVHD is poorly responsive to any available form of therapy and is almost always a fatal complication. Agents that have been tried without substantial success include corticosteroids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    , antithymocyte globulin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    . A number of experimental approaches have been reported, including ultraviolet irradiation, succinylacetone, inhibitors of the production of tumor necrosis factor such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/28/13765?source=see_link\">",
"     pentoxifylline",
"    </a>",
"    , interleukin-1 receptor antagonists, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29673?source=see_link\">",
"     thalidomide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/3,16-18\">",
"     3,16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A unique patient with chronic lymphocytic leukemia (CLL) has been reported, who fortunately had sufficient cryopreserved autologous peripheral blood stem cells available from a prior autologous hematopoietic cell transplantation (HCT) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/19\">",
"       19",
"      </a>",
"      ]. She developed ta-GVHD 10 days following transfusion of non-irradiated blood components, and was treated with solumedrol,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      , high-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      , antithymocyte globulin, and autologous HCT, with complete recovery from both the TA-GVHD and CLL.",
"     </li>",
"     <li>",
"      A non-lethal, attenuated case of ta-GVHD was seen in a seven-month-old boy with combined immunodeficiency who happened to be under high-dose glucocorticoid therapy (4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      ) at the time of the engraftment [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the absence of effective therapy, prevention is of primary importance. This can be best achieved by inactivating transfused lymphocytes by exposing all lymphocyte-containing components to gamma irradiation. This procedure should be followed for patients who are immunosuppressed, who have received a hematopoietic cell transplant (HCT), who are getting blood components from a family donor, or who are given HLA-matched platelets. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/37/21081?source=see_link&amp;anchor=H15#H15\">",
"     \"Use of red blood cells for transfusion\", section on 'Irradiated red cells'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20586?source=see_link&amp;anchor=H558381864#H558381864\">",
"     \"Clinical and laboratory aspects of platelet transfusion therapy\", section on 'Irradiation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In Japan, where there is reduced genetic variability and a high risk of ta-GVHD due to partial HLA matching, universal blood component irradiation has been instituted. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Partial HLA matching'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In rural Turkey, consanguineous marriage is common and, for patients needing blood, there is a tendency to transfuse fresh blood from relatives. In such a setting, especially when coupled with unavailability of irradiation, the risk of ta-GVHD may be quite high [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A fatal case of ta-GVHD attributed to partial HLA matching in an immunocompetent 82-year-old man following cardiac surgery has raised the question as to whether the current United States policy of selective irradiation of blood products should be revisited [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Irradiation procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Either a cesium-137 or cobalt-60 source can be used. The latter is usually present in radiation therapy departments and is less suited for irradiation of blood components. Thus, cesium-137 is the preferred source and is most often found in specifically designed, self-contained blood product irradiators.",
"   </p>",
"   <p>",
"    According to a memorandum from the Food and Drug Administration (dated July 22, 1993) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/12\">",
"     12",
"    </a>",
"    ], the dose of delivered irradiation should be 25 Gy, targeted to the central portion of the container and a minimum of 15 Gy to any other point. This dose should result in more than a 90 percent reduction in mitogen response, a five to six log reduction in T cell response to mitogen, and complete inhibition of the mixed lymphocyte culture response.",
"   </p>",
"   <p>",
"    Irradiation affects the allowable storage time for red cell-containing components, decreasing it to 28 days post-irradiation, due to changes in the red cell membrane that result in potassium leak. In addition, patients who may be unable to handle a potassium load (such as neonates) should have the plasma removed from irradiated red cell components that have been stored for more than two to three weeks after irradiation. Irradiation has no impact on the dating period for other cellular components.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Leukodepletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Third and fourth generation leukodepletion filters, which can produce a three to five log reduction in white cell number, can theoretically reduce the incidence of ta-GVHD. Although a United Kingdom surveillance study has indicated a reduction of this incidence after the institution of universal leukodepletion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/24\">",
"     24",
"    </a>",
"    ], employment of this procedure alone for the prevention of ta-GVHD is not fully protective, and leukodepletion should",
"    <strong>",
"     not",
"    </strong>",
"    be used as an alternative to gamma irradiation for those patients at increased risk of ta-GVHD [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/6,25,26\">",
"     6,25,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=see_link&amp;anchor=H10#H10\">",
"     \"Leukoreduction to prevent complications of blood transfusion\", section on 'Graft-versus-host disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, leukoreduction may provide some protection for immunocompetent recipients who are unknowingly exposed to an HLA homozygous donor who they do not recognize as foreign.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5549862\">",
"    <span class=\"h3\">",
"     Other methods for WBC inactivation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methods other than irradiation are able to inactivate white blood cells. This can be accomplished by the use of one of two systems that are nucleic acid-targeted pathogen reduction technologies (PRT; eg, the Intercept Blood System and the Mirasol PRT system). Each system employs the use of a chemical agent (amotosalen and riboflavin, respectively) and ultraviolet light. These PRT techniques are capable of reducing the active pathogen load as well as abrogating selected white cell immune functions and preventing T cell proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6710/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. These systems, which are not commercially available in the United States, have been employed as part of the routine practice for platelet transfusions in other countries, and many institutions using these systems are not gamma irradiating platelet products that otherwise would have undergone this treatment. No ta-GVHD has been reported with this practice to date.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17697373\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17697381\">",
"    <span class=\"h2\">",
"     Causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transfusion-associated graft versus host disease (ta-GVHD) does not occur after most transfusions because the donor lymphocytes are destroyed by the recipient's immune system before they can mount a response against the host. However, this protective response does not occur in two settings: when the recipient is immunodeficient, and when there is a specific type of partial HLA matching between the donor and recipient. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathogenesis and incidence'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17697388\">",
"    <span class=\"h2\">",
"     Implicated products",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ta-GVHD has been reported after the administration of nonirradiated whole blood, packed red cells, platelets, granulocytes, and fresh, non-frozen plasma. In comparison, ta-GVHD does not appear to be induced by frozen, deglycerolized red cells, fresh frozen plasma, or cryoprecipitate. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Implicated blood products'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17697427\">",
"    <span class=\"h2\">",
"     Presentation and diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;(see",
"    <a class=\"local\" href=\"#H6\">",
"     'Clinical presentation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H7\">",
"     'Diagnosis'",
"    </a>",
"    above)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ta-GVHD develops 4 to 30 days after blood transfusion. Patients typically present with fever and rash. Other symptoms include anorexia, vomiting, abdominal pain, profuse diarrhea, and cough.",
"     </li>",
"     <li>",
"      The main laboratory findings are pancytopenia due to a strikingly hypocellular marrow, abnormal liver function tests, and electrolyte abnormalities induced by diarrhea.",
"     </li>",
"     <li>",
"      The diagnosis is suggested from biopsy of affected skin, which classically reveals vacuolization of the basal layer and a histiocytic infiltrate, which is also seen in the aplastic bone marrow. The definitive diagnosis is established if the circulating lymphocytes are shown to have a different HLA phenotype from host tissue cells (ie, from the donor).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17697475\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;(see",
"    <a class=\"local\" href=\"#H8\">",
"     'Treatment and prevention'",
"    </a>",
"    above)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ta-GVHD is almost universally fatal; there is no effective treatment.",
"     </li>",
"     <li>",
"      Prevention can be best achieved by inactivating transfused lymphocytes by exposing all lymphocyte-containing components to gamma irradiation. This procedure should be followed for patients who are immunosuppressed, who have received a hematopoietic cell transplant (HCT), who are getting blood components from a family donor, or who are given HLA-matched platelets.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Certain pathogen reduction technologies, capable of reducing the active pathogen load as well as abrogating selected white cell immune functions and preventing T cell proliferation, are in current use in some countries, and serve as alternatives to gamma irradiation. (See",
"      <a class=\"local\" href=\"#H5549862\">",
"       'Other methods for WBC inactivation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Leukodepletion should",
"      <strong>",
"       not",
"      </strong>",
"      be used as an alternative to gamma irradiation for those patients at increased risk of ta-GVHD.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/1\">",
"      Linden JV, Pisciotto PT. Transfusion-associated graft-versus-host disease and blood irradiation. Transfus Med Rev 1992; 6:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/2\">",
"      Fast LD. Developments in the prevention of transfusion-associated graft-versus-host disease. Br J Haematol 2012; 158:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/3\">",
"      Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/4\">",
"      Hathaway WE, Githens JH, Blackburn WR, et al. Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease. N Engl J Med 1965; 273:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/5\">",
"      Brubaker DB. Human posttransfusion graft-versus-host disease. Vox Sang 1983; 45:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/6\">",
"      Schroeder ML. Transfusion-associated graft-versus-host disease. Br J Haematol 2002; 117:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/7\">",
"      Maung ZT, Wood AC, Jackson GH, et al. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 1994; 88:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/8\">",
"      Leitman SF, Tisdale JF, Bolan CD, et al. Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion 2003; 43:1667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/9\">",
"      Sakakibara T, Juji T. Post-transfusion graft-versus-host disease after open heart surgery. Lancet 1986; 2:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/10\">",
"      Shivdasani RA, Haluska FG, Dock NL, et al. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med 1993; 328:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/11\">",
"      Aoun E, Shamseddine A, Chehal A, et al. Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center. Transfusion 2003; 43:1672.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Memorandum: License amendments and procedures for gamma irradiation of blood products. June 22, 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/13\">",
"      von Fliedner V, Higby DJ, Kim U. Graft-versus-host reaction following blood product transfusion. Am J Med 1982; 72:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/14\">",
"      Leitman SF, Holland PV. Irradiation of blood products. Indications and guidelines. Transfusion 1985; 25:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/15\">",
"      De Dobbeleer GD, Ledoux-Corbusier MH, Achten GA. Graft versus host reaction. An ultrastructural study. Arch Dermatol 1975; 111:1597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/16\">",
"      Woods WG, Lubin BH. Fatal graft versus host disease following a blood transfusion in a child with neuroblastoma. Pediatrics 1981; 67:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/17\">",
"      Rosen RC, Huestis DW, Corrigan JJ Jr. Acute leukemia and granulocyte transfusion: Fatal graft-versus-host reaction following transfusion of cells obtained from normal donors. J Pediatr 1978; 93:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/18\">",
"      Betzhold J, Hong R. Fatal graft-versus-host disease after a small leukocyte transfusion in a patient with lymphoma and varicella. Pediatrics 1978; 62:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/19\">",
"      Hutchinson K, Kopko PM, Muto KN, et al. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion 2002; 42:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/20\">",
"      Neves JF, Marques A, Valente R, Barata D. Nonlethal, attenuated, transfusion-associated graft-versus-host disease in an immunocompromised child: case report and review of the literature. Transfusion 2010; 50:2484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/21\">",
"      Agbaht K, Altintas ND, Topeli A, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature. Transfusion 2007; 47:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/22\">",
"      Triulzi D, Duquesnoy R, Nichols L, et al. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion 2006; 46:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/23\">",
"      Klein HG. Transfusion-associated graft-versus-host disease: less fresh blood and more gray (Gy) for an aging population. Transfusion 2006; 46:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/24\">",
"      Williamson LM, Stainsby D, Jones H, et al. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion 2007; 47:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/25\">",
"      Akahoshi M, Takanashi M, Masuda M, et al. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion 1992; 32:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/26\">",
"      Hayashi H, Nishiuchi T, Tamura H, Takeda K. Transfusion-associated graft-versus-host disease caused by leukocyte-filtered stored blood. Anesthesiology 1993; 79:1419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/27\">",
"      Fast LD, DiLeone G, Marschner S. Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Transfusion 2011; 51:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6710/abstract/28\">",
"      Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999; 93:3140.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7928 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-A7177AF1CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6710=[""].join("\n");
var outline_f6_35_6710=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17697373\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS AND INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Immunodeficient states",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Partial HLA matching",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Implicated blood products",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TREATMENT AND PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Irradiation procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Leukodepletion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5549862\">",
"      - Other methods for WBC inactivation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17697373\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17697381\">",
"      Causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17697388\">",
"      Implicated products",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17697427\">",
"      Presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17697475\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20586?source=related_link\">",
"      Clinical and laboratory aspects of platelet transfusion therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=related_link\">",
"      Leukoreduction to prevent complications of blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/37/21081?source=related_link\">",
"      Use of red blood cells for transfusion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_35_6711="HSTCL liver 40x magnification";
var content_f6_35_6711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F50070&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F50070&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Hepatosplenic T-cell lymphoma tumor cells in the sinuses of the liver",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Higher magnification of the liver biopsy shows clusters of tumor cells in the sinuses. Hematoxylin and eosin, 40x magnification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sun T. Clinical application. In: Flow Cytometry and Immunochemistry for Hematologic Neoplasms, Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6711=[""].join("\n");
var outline_f6_35_6711=null;
var title_f6_35_6712="Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin";
var content_f6_35_6712=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of Merkel cell (neuroendocrine) carcinoma and sebaceous cell carcinoma of the skin",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6712/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6712/contributors\">",
"     Patricia Tai, MB, BS, DABR, FRCR, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6712/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6712/contributors\">",
"     Robert S Stern, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6712/contributors\">",
"     June K Robinson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6712/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6712/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/35/6712/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Merkel cell carcinoma (MCC) of the skin is a rare, aggressive cutaneous malignancy that predominantly affects elderly Caucasians and has a propensity for local recurrence and regional lymph node metastases. A variety of other terms have been used to describe this tumor, including neuroendocrine or primary small cell carcinoma of the skin, trabecular cell carcinoma, APUDoma of the skin, and anaplastic cancer of the skin.",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical features, and diagnosis of MCC are discussed here. Sebaceous carcinoma arising in the skin is also discussed here. The staging and treatment of patients with MCC are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3577?source=see_link\">",
"     \"Staging and treatment of Merkel cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;MCC was first described in 1972 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/1\">",
"     1",
"    </a>",
"    ]. Data from the Surveillance, Epidemiology and End Results (SEER) Program database indicate that MCC is uncommon; the estimated annual incidence rate in 2006 was 0.6 per 100,000 persons [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/2\">",
"     2",
"    </a>",
"    ]. Incidence rates were higher in males compared with females (0.41 and 0.18 cases per 100,000 person-years, respectively).",
"   </p>",
"   <p>",
"    MCC predominantly affects white persons. A study analyzing SEER data from 1973 to 2006 found that 95 percent of cases diagnosed during this interval arose in the white population [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MCC is typically seen in older individuals, with a mean age at diagnosis of 76 years for women and 74 years for men [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/2\">",
"     2",
"    </a>",
"    ]. However, MCC occurs at a younger age in immunosuppressed subjects, including organ transplant recipients, patients with B cell malignancies, and those infected with HIV. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Immunosuppression'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The risk of MCC is significantly increased in patients with other malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In a SEER database study of over two million patients with cancer, the risk of MCC was significantly increased in those with multiple myeloma, chronic lymphocytic leukemia, and malignant melanoma (standardized incidence ratios [SIRs] 3.7, 6.9, and 3.1, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/3\">",
"     3",
"    </a>",
"    ]. &nbsp;During the first year after diagnosis, patients with a primary diagnosis of MCC had a significantly increased incidence of second cancers of the salivary gland, biliary tract, and non-Hodgkin lymphoma (SIRs 11.6, 7.2, and 2.6, respectively).",
"   </p>",
"   <p>",
"    A retrospective study of 4164 patients with chronic lymphocytic leukemia and 172 patients with MCC supported the association between these two disorders reported in the SEER database study [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/5\">",
"     5",
"    </a>",
"    ]. Among patients with a diagnosis of chronic lymphocytic leukemia, the incidence of a subsequent diagnosis of MCC was greatly elevated (SIR 15.7, 95% CI 3.2-46.0). Patients with a preceding diagnosis of MCC also exhibited an increased risk for developing chronic lymphocytic leukemia (SIR 17.9, 95% CI 2.2-64.6).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;MCC is believed to arise from Merkel cells that are located in the basal layer of the epidermis and hair follicles, although this is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/6\">",
"     6",
"    </a>",
"    ]. Merkel cells are associated with sensory neurites in the dermal papillae, which are the mechanoreceptors in the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/7\">",
"     7",
"    </a>",
"    ]. However, the majority of MCCs are intradermal, and only 10 percent of MCCs arise in the epidermis. An alternative hypothesis is that these tumors originate from an immature totipotential stem cell that acquires neuroendocrine features during malignant transformation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several factors have been associated with the development of MCC. These include ultraviolet (UV) radiation exposure, infection with the Merkel cell polyomavirus, and immunosuppression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     UV radiation exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultraviolet (UV) radiation exposure, especially to the sun, is thought to play an important role in the etiology of many cases of MCC. The following observations are consistent with an etiologic role for UV radiation exposure:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MCC has a predilection for sun-exposed areas. In a study of the clinical manifestations 195 cases of MCC, tumor arose in a UV exposed region in 81 percent of assessable cases [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/9\">",
"       9",
"      </a>",
"      ]. Furthermore, 98 percent of cases occurred in fair skinned individuals.",
"     </li>",
"     <li>",
"      Regional incidence rates correlate with increasing sun exposure, as measured by the UVB solar index [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/10,11\">",
"       10,11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Presentation with other skin cancers for which sun exposure is a major risk factor is common [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/4,12\">",
"       4,12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link\">",
"       \"Epidemiology and clinical features of basal cell carcinoma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/56/25482?source=see_link\">",
"       \"Epidemiology and risk factors for cutaneous squamous cell carcinoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      MCC has been described in patients treated with PUVA (psoralen + ultraviolet A photochemotherapy) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      At least one report described a typical ultraviolet-B-induced mutation in a MCC [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Merkel cell polyomavirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Merkel cell polyomavirus is a non-enveloped, double-stranded DNA virus that may be causally linked to the development of MCC (",
"    <a class=\"graphic graphic_picture graphicRef61586 \" href=\"UTD.htm?14/34/14890\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. The observation that the integration of the virus into the tumor genome precedes the clonal expansion of tumor cells supports a pathogenic role for this virus [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/15,19\">",
"     15,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reported prevalence rates for Merkel cell polyomavirus in tumors of MCC vary, but most studies have found the virus in around 80 percent of MCCs [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/15,16,20,21\">",
"     15,16,20,21",
"    </a>",
"    ]. However, a study that utilized new techniques to detect the virus found evidence to suggest that Merkel cell polyomavirus may be present in all MCC tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/22\">",
"     22",
"    </a>",
"    ]. In the study, use of an expanded repertoire of PCR primers led to the detection of viral DNA in all 60 tumor specimens tested. In addition, use of a novel monoclonal antibody against the Merkel cell polyomavirus T antigen resulted in the detection of the virus in 56 of 58 tumors (97 percent). The two tumors that stained negatively for the novel antibody were found to have inactivating mutations in the",
"    <em>",
"     TP53",
"    </em>",
"    gene, a gene that encodes the tumor suppressor protein p53.",
"   </p>",
"   <p>",
"    Of note, Merkel cell polyomavirus is not limited to sites of MCC tumor development; the virus has been detected in normal-appearing skin and in some cutaneous squamous cell carcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/23-27\">",
"     23-27",
"    </a>",
"    ]. In one series of patients with MCC, skin samples taken from sites distant from the tumor were positive for the virus in 10 out of 14 cases (71 percent), a frequency higher than was observed in six skin samples from normal individuals (17 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of MCC is increased in immunosuppressed patients, including organ transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/28-32\">",
"     28-32",
"    </a>",
"    ], HIV-infected individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/33,34\">",
"     33,34",
"    </a>",
"    ], and those with B-cell malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/3,9\">",
"     3,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37832?source=see_link&amp;anchor=H7860407#H7860407\">",
"     \"Epidemiology and risk factors for skin cancer in solid organ transplant recipients\", section on 'Merkel cell carcinoma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link&amp;anchor=H1560506410#H1560506410\">",
"     \"HIV infection and malignancy: Management considerations\", section on 'Merkel cell carcinoma and other neuroendocrine tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indirect evidence supporting a role for the immune system in the pathogenesis of MCC comes from the observations of spontaneous remissions, which are thought to be immune-mediated [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/35-39\">",
"     35-39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with MCC typically present with a rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule (",
"    <a class=\"graphic graphic_picture graphicRef70535 graphicRef50573 graphicRef52988 \" href=\"UTD.htm?1/44/1738\">",
"     picture 2A-C",
"    </a>",
"    ). A study utilizing data from 3778 cases of MCC in the SEER Program registry from 1973 to 2006 found that the most frequent anatomic locations for the primary tumor were the following [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Face - 27 percent",
"     </li>",
"     <li>",
"      Upper limbs and shoulder - 22 percent",
"     </li>",
"     <li>",
"      Lower limbs and hip - 15 percent",
"     </li>",
"     <li>",
"      Trunk - 11 percent",
"     </li>",
"     <li>",
"      Scalp and neck - 9 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A high index of suspicion is required if the diagnosis is to be made without delay. The clinical parameters usually associated with the diagnosis of MCC are illustrated by a series of 195 cases seen over a period of 27 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asymptomatic - 88 percent",
"     </li>",
"     <li>",
"      Expanding rapidly - 63 percent",
"     </li>",
"     <li>",
"      Immune suppressed - 8 percent",
"     </li>",
"     <li>",
"      Age &ge; 50 years - 90 percent",
"     </li>",
"     <li>",
"      UV exposed area - 81 percent in a fair-skinned individual (98 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In this series, lesions were often large (43 percent 1 to 2 cm and 35 percent greater than 2 cm); only 21 percent were less than 1 cm. In 14 percent of cases, patients presented with regional lymphadenopathy, without an identifiable primary tumor.",
"   </p>",
"   <p>",
"    In several large series, 60 to 75 percent of patients had localized disease at presentation, while 10 to 25 percent had regional lymph node involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/12,40,41\">",
"     12,40,41",
"    </a>",
"    ]. Presentation with metastatic disease is relatively uncommon and has been observed in 2 to 8 percent of cases. In some patients who present with regional lymph node or distant metastases, a primary tumor cannot be detected [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3577?source=see_link&amp;anchor=H12500421#H12500421\">",
"     \"Staging and treatment of Merkel cell carcinoma\", section on 'Unknown primary'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although distant metastases are uncommon at presentation, one-third to one-half of patients with MCC eventually develop systemic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. The most commonly involved sites are liver, bone, brain, and skin [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histologic examination of a biopsy is required to establish the diagnosis of MCC. Both routine studies with hematoxylin and eosin as well as immunohistochemistry are usually required to distinguish MCC from other poorly differentiated tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;MCC usually arises in the dermis and extends into the subcutis. The epidermis is infrequently involved, and the overlying skin is rarely ulcerated. There are three main histologic patterns, which have not been demonstrated to have prognostic or therapeutic implications (",
"    <a class=\"graphic graphic_picture graphicRef76388 \" href=\"UTD.htm?19/25/19863\">",
"     picture 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intermediate type, which is most common",
"     </li>",
"     <li>",
"      Trabecular type",
"     </li>",
"     <li>",
"      Small cell type",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Various histologic features were correlated with prognosis in a retrospective series of 156 patients with MCC [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/43\">",
"     43",
"    </a>",
"    ]. When clinical stage was incorporated into a multivariate analysis, only lymphovascular invasion and an infiltrative, rather than a nodular, growth pattern were associated with a poorer prognosis (odds ratios [ORs] for death 3.8 and 6.9, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of MCC by conventional light microscopy is difficult due to its similarity to other poorly differentiated \"small blue cell tumors\" (small cell carcinoma of the lung, cutaneous large cell lymphoma, neuroblastoma, metastatic carcinoid, amelanotic melanoma, sweat gland carcinoma, Langerhans cell histiocytosis, Ewing sarcoma) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/44\">",
"     44",
"    </a>",
"    ]. Ancillary techniques, including electron microscopy and immunohistochemistry, are usually required for a definitive diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/45-47\">",
"     45-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On immunohistochemistry, the Merkel cell has properties of both epithelial and neuroendocrine cells [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/45\">",
"     45",
"    </a>",
"    ]. Immunoreactivity for intermediate filaments such as the cytokeratins distinguishes MCC from other undifferentiated tumors (",
"    <a class=\"graphic graphic_table graphicRef54954 \" href=\"UTD.htm?14/40/14988\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/48\">",
"     48",
"    </a>",
"    ]. MCC consistently stains positively for cytokeratin 20. The immunohistochemical detection of intermediate filaments, thyroid transcription factor-1 (TTF-1) and neuroendocrine markers in an undifferentiated dermal tumor is useful in differentiating MCC from metastatic small cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/7,49\">",
"     7,49",
"    </a>",
"    ]. Definitive diagnosis also requires negative reactivity for S100, leukocyte common antigen, and high molecular weight cytokeratins (",
"    <a class=\"graphic graphic_picture graphicRef80961 \" href=\"UTD.htm?28/5/28759\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/46,48\">",
"     46,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrastructurally, tumor cells, like normal Merkel cells, contain paranuclear electron-dense neurosecretory granules (dense core granules), 10 mm filaments, and desmosomes [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cytogenetic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple chromosome abnormalities including gains, losses, and rearrangements have been detected in MCC. However, the relationship of these genetic changes to pathogenesis, natural history, and therapeutic outcomes is unclear. The chromosomes most frequently affected are 1, 11, and 13 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]; the pattern of chromosome gains and losses are similar to those seen in small cell cancer of the lung (SCLC) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=see_link\">",
"     \"Pathobiology and staging of small cell carcinoma of the lung\"",
"    </a>",
"    .) Structural abnormalities involving chromosome 1p have been noted in up to 40 percent of examined cases [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mutations in tumor suppressor genes may also be present. These include p73, the gene which is located on chromosome 1p, p53 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/14\">",
"     14",
"    </a>",
"    ], and loss of heterozygosity in chromosome 3p21, a region that is also affected in a large number of cases of SCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SEBACEOUS CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sebaceous carcinoma is a rare tumor arising in sebaceous glands of the skin. A review of the entire Surveillance, Epidemiology and End Results (SEER) database from 1973 to 2004 identified 1349 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/55\">",
"     55",
"    </a>",
"    ]. More than 90 percent of cases were seen in patients over 50 years old. Sebaceous carcinoma was more common in whites than in other ethnic groups and was slightly more common in men (54 percent).",
"   </p>",
"   <p>",
"    Approximately 80 percent of cases arose in the skin of the head or neck. The most common site was the skin of the eyelids, which accounted for 39 percent overall (",
"    <a class=\"graphic graphic_picture graphicRef70403 \" href=\"UTD.htm?10/8/10370\">",
"     picture 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef77552 \" href=\"UTD.htm?15/20/15685\">",
"     picture 6",
"    </a>",
"    ). Confusion with other lesions arising in the eyelid is an important factor that may lead to a delay in diagnosis and a worsening of prognosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4088?source=see_link&amp;anchor=H16#H16\">",
"     \"Eyelid lesions\", section on 'Sebaceous carcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sebaceous carcinoma has been associated with a number of second malignancies, primarily those seen with the Muir-Torre syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\", section on 'Muir-Torre and Turcot variants of Lynch syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sebaceous carcinoma is generally managed with surgical resection of the primary lesion to ensure adequate tumor-free margins, although there are no studies comparing surgery with radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/57\">",
"     57",
"    </a>",
"    ]. In the SEER database, the five- and ten-year overall survival rates compared to the age-matched population were 92 and 79 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6712/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Merkel cell carcinoma (MCC) is a rare cutaneous malignancy with a propensity for local recurrence and regional lymph node metastases.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidemiologically, the incidence of MCC has been increasing rapidly, primarily in fair-skinned Caucasians. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple factors appear to contribute to the etiology of MCC, including ultraviolet radiation exposure, the Merkel cell polyomavirus, and various types of occult or overt immunosuppression. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis is made by histologic examination of a biopsy specimen, and generally requires immunohistochemistry as well as routine staining to distinguish MCC from other poorly differentiated tumors. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The staging and management of patients with MCC is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3577?source=see_link\">",
"       \"Staging and treatment of Merkel cell carcinoma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/1\">",
"      Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/2\">",
"      Albores-Saavedra J, Batich K, Chable-Montero F, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010; 37:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/3\">",
"      Howard RA, Dores GM, Curtis RE, et al. Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 2006; 15:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/4\">",
"      Kaae J, Hansen AV, Biggar RJ, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst 2010; 102:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/5\">",
"      Koljonen V, Kukko H, Pukkala E, et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 2009; 101:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/6\">",
"      Foschini MP, Eusebi V. Divergent differentiation in endocrine and nonendocrine tumors of the skin. Semin Diagn Pathol 2000; 17:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/7\">",
"      Ratner D, Nelson BR, Brown MD, Johnson TM. Merkel cell carcinoma. J Am Acad Dermatol 1993; 29:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/8\">",
"      Hoefler H, Denk H, Lackinger E, et al. Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumours. Virchows Arch A Pathol Anat Histopathol 1986; 409:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/9\">",
"      Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008; 58:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/10\">",
"      Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/11\">",
"      Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/12\">",
"      Zhan FQ, Packianathan VS, Zeitouni NC. Merkel cell carcinoma: a review of current advances. J Natl Compr Canc Netw 2009; 7:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/13\">",
"      Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998; 339:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/14\">",
"      Van Gele M, Kaghad M, Leonard JH, et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000; 82:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/15\">",
"      Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/16\">",
"      Kassem A, Sch&ouml;pflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 2008; 68:5009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/17\">",
"      Sharp CP, Norja P, Anthony I, et al. Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. J Infect Dis 2009; 199:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/18\">",
"      Carter JJ, Paulson KG, Wipf GC, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/19\">",
"      Sastre-Garau X, Peter M, Avril MF, et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 2009; 218:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/20\">",
"      Schrama D, Peitsch WK, Zapatka M, et al. Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. J Invest Dermatol 2011; 131:1631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/21\">",
"      Sihto H, Kukko H, Koljonen V, et al. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/22\">",
"      Rodig SJ, Cheng J, Wardzala J, et al. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 2012; 122:4645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/23\">",
"      Foulongne V, Dereure O, Kluger N, et al. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol 2010; 162:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/24\">",
"      Kassem A, Technau K, Kurz AK, et al. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 2009; 125:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/25\">",
"      Rollison DE, Giuliano AR, Messina JL, et al. Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2012; 21:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/26\">",
"      Murakami M, Imajoh M, Ikawa T, et al. Presence of Merkel cell polyomavirus in Japanese cutaneous squamous cell carcinoma. J Clin Virol 2011; 50:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/27\">",
"      Dworkin AM, Tseng SY, Allain DC, et al. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol 2009; 129:2868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/28\">",
"      Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/29\">",
"      Bajetta E, Platania M, Catena L, et al. Merkel cell carcinoma after liver transplantation: a case report. Tumori 2007; 93:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/30\">",
"      Bensaleh H, Perney P, Dereure O, et al. Merkel cell carcinoma in a liver transplant patient. Am J Clin Dermatol 2007; 8:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/31\">",
"      Koljonen V, Kukko H, Tukiainen E, et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009; 24:3231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/32\">",
"      Tadmor T, Aviv A, Polliack A. Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol 2011; 22:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/33\">",
"      Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcinoma and HIV infection. Lancet 2002; 359:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/34\">",
"      Manganoni MA, Farisoglio C, Tucci G, et al. Merkel cell carcinoma and HIV infection: a case report and review of the literature. AIDS Patient Care STDS 2007; 21:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/35\">",
"      Yanguas I, Goday JJ, Gonz&aacute;lez-G&uuml;emes M, et al. Spontaneous regression of Merkel cell carcinoma of the skin. Br J Dermatol 1997; 137:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/36\">",
"      Connelly TJ, Kowalcyk AP. Another case of spontaneous regression of Merkel cell (neuroendocrine) carcinoma. Dermatol Surg 1997; 23:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/37\">",
"      Richetta AG, Mancini M, Torroni A, et al. Total spontaneous regression of advanced merkel cell carcinoma after biopsy: review and a new case. Dermatol Surg 2008; 34:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/38\">",
"      Yagi Y, Fujisawa A, Makiura M, Morita K. Spontaneous regression of Merkel cell carcinoma after biopsy. J Dermatol 2009; 36:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/39\">",
"      Karkos PD, Sastry A, Hampal S, Al-Jafari M. Spontaneous regression of Merkel cell carcinoma of the nose. Head Neck 2010; 32:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/40\">",
"      Yu E, Tonita J, Gilchrist J. Merkel cell carcinoma of the skin. J Cutan Med Surg 2000; 4:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/41\">",
"      Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23:2300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/42\">",
"      Tarantola TI, Vallow LA, Halyard MY, et al. Unknown primary Merkel cell carcinoma: 23 new cases and a review. J Am Acad Dermatol 2013; 68:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/43\">",
"      Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113:2549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/44\">",
"      Smith DF, Messina JL, Perrott R, et al. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control 2000; 7:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/45\">",
"      Warner TF, Uno H, Hafez GR, et al. Merkel cells and Merkel cell tumors. Ultrastructure, immunocytochemistry and review of the literature. Cancer 1983; 52:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/46\">",
"      Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases. Am J Surg Pathol 1985; 9:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/47\">",
"      Meyer-Pannwitt U, Kummerfeldt K, Boubaris P, Caselitz J. [Merkel cell tumor or neuroendocrine skin carcinoma]. Langenbecks Arch Chir 1997; 382:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/48\">",
"      Chan JK, Suster S, Wenig BM, et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997; 21:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/49\">",
"      Leech SN, Kolar AJ, Barrett PD, et al. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol 2001; 54:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/50\">",
"      Leonard JH, Leonard P, Kearsley JH. Chromosomes 1, 11, and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma. Cancer Genet Cytogenet 1993; 67:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/51\">",
"      Van Gele M, Speleman F, Vandesompele J, et al. Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998; 58:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/52\">",
"      Sozzi G, Bertoglio MG, Pilotti S, et al. Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma. Cancer Genet Cytogenet 1988; 30:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/53\">",
"      Van Gele M, Van Roy N, Ronan SG, et al. Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas. Genes Chromosomes Cancer 1998; 23:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/54\">",
"      Leonard JH, Williams G, Walters MK, et al. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma. Genes Chromosomes Cancer 1996; 15:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/55\">",
"      Dores GM, Curtis RE, Toro JR, et al. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome. Cancer 2008; 113:3372.",
"     </a>",
"    </li>",
"    <li>",
"     Solan MJ, Brady LW. Skin cancer. In: Principles and practice of radiation oncology, 5th, Halperin EC, Pereze CA, Brady LW (Eds), Lippincott, Williams and Wilkins, Philadelphia 2008. p.700.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6712/abstract/57\">",
"      Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer 2009; 115:158.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7623 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-217.117.136.88-D8E73D39BC-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6712=[""].join("\n");
var outline_f6_35_6712=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      UV radiation exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Merkel cell polyomavirus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cytogenetic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SEBACEOUS CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/7623\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/7623|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/34/14890\" title=\"picture 1\">",
"      Merkel cell carcinoma - polyomavirus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/61/2001\" title=\"picture 2A\">",
"      Merkel cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/41/8852\" title=\"picture 2B\">",
"      Merkel cell carcinoma - face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/49/25362\" title=\"picture 2C\">",
"      Merkel cell carcinoma - forearm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/25/19863\" title=\"picture 3\">",
"      Variant histologies merkel cell",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/5/28759\" title=\"picture 4\">",
"      Cytokeratin stain Merkel cell",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/8/10370\" title=\"picture 5\">",
"      Sebac cell ca",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/20/15685\" title=\"picture 6\">",
"      Sebaceous cell carcinoma eyelid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/7623|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/40/14988\" title=\"table 1\">",
"      IHC stain Merkel cell carcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/56/25482?source=related_link\">",
"      Epidemiology and risk factors for cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37832?source=related_link\">",
"      Epidemiology and risk factors for skin cancer in solid organ transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4088?source=related_link\">",
"      Eyelid lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=related_link\">",
"      HIV infection and malignancy: Management considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=related_link\">",
"      Pathobiology and staging of small cell carcinoma of the lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3577?source=related_link\">",
"      Staging and treatment of Merkel cell carcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_35_6713="Mycoplasma pneumoniae infection in children";
var content_f6_35_6713=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mycoplasma pneumoniae infection in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6713/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6713/contributors\">",
"     Dori F Zaleznik, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6713/contributors\">",
"     Jesus G Vallejo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6713/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6713/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/35/6713/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/35/6713/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/35/6713/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Mycoplasma pneumoniae",
"    </em>",
"    is one of three species of",
"    <em>",
"     Mycoplasma",
"    </em>",
"    that frequently produce infection in humans. Mycoplasmas are ubiquitous and are the smallest bacteria that can survive alone in nature.",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    causes a wide variety of clinical manifestations in children and adults, principally pneumonia.",
"   </p>",
"   <p>",
"    The clinical features, diagnosis, and treatment of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection in children will be reviewed here.",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection in adults,",
"    <em>",
"     M. hominis, M genitalium, and Ureaplasma urealyticum",
"    </em>",
"    infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3162?source=see_link\">",
"     \"Mycoplasma pneumoniae infection in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/28/31177?source=see_link\">",
"     \"Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"mycoplasma\" is widely used to refer to any organism within the class Mollicutes, which is composed of five genera (",
"    <em>",
"     Mycoplasma",
"    </em>",
"    ,",
"    <em>",
"     Ureaplasma",
"    </em>",
"    ,",
"    <em>",
"     Acholeplasma",
"    </em>",
"    ,",
"    <em>",
"     Anaeroplasma",
"    </em>",
"    , and",
"    <em>",
"     Asteroloplasma",
"    </em>",
"    ). More than 120 named",
"    <em>",
"     Mycoplasma",
"    </em>",
"    species exist, and 13",
"    <em>",
"     Mycoplasma",
"    </em>",
"    species, two",
"    <em>",
"     Acholeplasma",
"    </em>",
"    species, and one",
"    <em>",
"     Ureaplasma",
"    </em>",
"    species have been isolated from humans. However, only four species are well-established human pathogens [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <em>",
"       Mycoplasma pneumoniae",
"      </em>",
"     </li>",
"     <li>",
"      <em>",
"       Mycoplasma hominis",
"      </em>",
"     </li>",
"     <li>",
"      <em>",
"       Mycoplasma genitalium",
"      </em>",
"     </li>",
"     <li>",
"      <em>",
"       Ureaplasma urealyticum",
"      </em>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    grows under both aerobic and anaerobic conditions and can be isolated on media supplemented with serum. The organism is fastidious, and isolation is not commonly performed in clinical laboratories.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism by which mycoplasmas produce infection is becoming better understood. Pathogenic organisms for humans and animals possess specialized tip organelles that mediate their interactions with host cells [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/2\">",
"     2",
"    </a>",
"    ]. This host-adapted survival is achieved by surface parasitism of target cells, the acquisition of essential biosynthetic precursors, and, in some cases, cell entry and intracellular survival. The organism most commonly exists in a filamentous form and has adherence proteins that attach to epithelial membranes with particular affinity for respiratory tract epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once attached,",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    produces",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    and superoxide, causing injury to epithelial cells and their associated cilia. However, many of the pathogenic features of infection with",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    are believed to be immune-mediated rather than induced directly by the bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. An immune-mediated mechanism is supported by the finding that infants and young children infrequently develop pneumonia despite evidence of infection. In addition, the antibodies produced against the glycolipid antigens of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    may act as autoantibodies because they crossreact with human red cells and brain cells [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    is transmitted from person to person by infected respiratory droplets during close contact. The incubation period after exposure averages three weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/7\">",
"     7",
"    </a>",
"    ]. Infection occurs most frequently during the fall and winter but may develop year-round [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the frequency of pneumonia caused by all respiratory pathogens decreases in children older than the age of five years, the relative importance of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    rises during the school years.",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    accounts for approximately 20 percent of acute pneumonias in middle and high school students and up to 50 percent of cases in college students and military recruits [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/8\">",
"     8",
"    </a>",
"    ]. The cumulative attack rate in families approaches 90 percent, and immunity is not long lasting [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many infections caused by",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    are asymptomatic. When present, the signs and symptoms vary according to the stage of illness (",
"    <a class=\"graphic graphic_figure graphicRef59329 \" href=\"UTD.htm?41/0/41986\">",
"     figure 1",
"    </a>",
"    ). The onset of the illness is gradual and usually is heralded by headache, malaise, and low-grade fever [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Chills are frequent, but rigors are rare. Patient complaints usually exceed objective findings because abnormalities on physical examination often are minimal.",
"   </p>",
"   <p>",
"    Symptoms and signs caused by",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection can be divided into those caused by respiratory tract and those caused by extrapulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/7\">",
"     7",
"    </a>",
"    ]. None of these manifestations are unique to",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Respiratory tract disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many more patients with respiratory infection caused by",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    have a respiratory tract illness without pneumonia than have pneumonia. In one review, for example, 75 to 100 percent of infected patients had an intractable, nonproductive cough, while only 3 to 10 percent developed pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cough caused by",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection ranges from nonproductive to mildly productive. Wheezing and dyspnea also may occur, although dyspnea is not a common complaint. Chills are common, but rigors are very rare.",
"   </p>",
"   <p>",
"    Additional respiratory symptoms include pharyngitis (6 to 59 percent of patients), rhinorrhea (2 to 40 percent), and ear pain (2 to 35 percent). As many as 5 percent of patients have severe ear pain resulting from hemorrhagic bullous myringitis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/5\">",
"     5",
"    </a>",
"    ], although one study using polymerase chain reaction (PCR)-based testing failed to document",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    in bullous or hemorrhagic myringitis in children under the age of two years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/13\">",
"     13",
"    </a>",
"    ]. Clinically inapparent sinusitis may coexist with pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There may be no findings on chest auscultation even if pneumonia is present early in the course of disease. However, scattered rales, wheezes, or both may develop later [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/7\">",
"     7",
"    </a>",
"    ]. Other physical findings related to the respiratory tract may include sinus tenderness, mild erythema of the posterior pharynx, erythema or occasionally bullae of the tympanic membrane, and nonprominent cervical adenopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Possible relation to asthma",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection may worsen asthma symptoms and can produce wheezing in children who do not have asthma. A separate question, for which there has been some experimental and clinical evidence, is whether M. pneumoniae might have some pathogenic role in asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This issue was addressed in a prospective study of children hospitalized for severe asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/15\">",
"     15",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 119 children with previously diagnosed asthma, acute",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      infection was found in 20 percent and",
"      <em>",
"       Chlamydophila",
"      </em>",
"      (",
"      <em>",
"       Chlamydia",
"      </em>",
"      )",
"      <em>",
"       pneumoniae",
"      </em>",
"      infection in 3.4 percent. The diagnosis of acute infection was made serologically from either an IgM response or at least a fourfold rise in IgG titers between the first and second samples.",
"     </li>",
"     <li>",
"      Among 51 children with a first asthmatic attack, acute",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      infection was found in 50 percent and",
"      <em>",
"       C. pneumoniae",
"      </em>",
"      infection in 8.3 percent.",
"     </li>",
"     <li>",
"      Among 152 controls with stable asthma or rhinitis,",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      infection was present in 5.2 percent.",
"     </li>",
"     <li>",
"      At follow-up, the patients infected with",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      or",
"      <em>",
"       C. pneumoniae",
"      </em>",
"      were more likely to have recurrent asthma than those without these infections. Among infected patients, recurrences tended to be rapid if the patient was not treated with a macrolide antibiotic.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further data are needed before routine testing for atypical organisms can be recommended in acute wheezing illnesses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30424?source=see_link\">",
"     \"Approach to wheezing in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/41/1689?source=see_link\">",
"     \"Wheezing illnesses other than asthma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A prospective study suggested that the immune response to",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    was altered in children with asthma compared to controls without asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/16\">",
"     16",
"    </a>",
"    ]. In this study, fewer of the asthmatic children had an IgG response to",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    over the five-year period (3 of 82 versus 13 of 98 controls, p = 0.03). The number of patients positive for IgM antibody did not differ between the groups. Cellular immune responses in mononuclear cells were greater in those with measurable IgM than in children without IgM, whether or not they had asthma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Extrapulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extrapulmonary abnormalities are an important part of mycoplasma disease and may suggest the diagnosis. These manifestations include hemolysis, skin rash, joint involvement, and symptoms and signs indicative of gastrointestinal tract, central nervous system (CNS), and heart disease. Whether the pathogenesis of some or all of these entities is caused by immune mechanisms or the direct action of the organisms is not clear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibodies (IgM) to the I antigen on erythrocyte membranes appear during the course of infection and produce a cold agglutinin response in approximately 60 percent of patients. Why mycoplasma infections promote the production of such antibodies and their significance in pathogenesis is not known. Although hemolysis may be severe, usually it is not clinically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H101020033\">",
"     'Cold agglutinins'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30535?source=see_link\">",
"     \"Pathogenesis of autoimmune hemolytic anemia: Cold agglutinin disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Skin disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermatologic manifestations may range from a mild erythematous maculopapular or vesicular rash (which is most commonly seen accompanying respiratory tract infections) to the Stevens-Johnson syndrome. M. pneumoniae is a common infectious cause of Stevens-Johnson syndrome in children. Antibiotics may intensify the dermatosensitive potential of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=see_link&amp;anchor=H6#H6\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\", section on 'Etiologies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One report cites a case of papular purpuric gloves and socks syndrome ascribed to",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection in an adolescent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/18\">",
"     18",
"    </a>",
"    ]. Papular purpuric gloves and socks syndrome usually is associated with parvovirus B19 infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\", section on 'Erythema infectiosum'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     CNS involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;CNS manifestations occur in approximately 0.1 percent of all patients with",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infections and in as many as 7 percent of patients requiring hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/19\">",
"     19",
"    </a>",
"    ]. CNS involvement occurs most frequently in children and includes aseptic meningitis, meningoencephalitis (which may be complicated by postencephalitic epilepsy), peripheral neuropathy, transverse myelitis, cranial nerve palsies, and cerebellar ataxia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/20-25\">",
"     20-25",
"    </a>",
"    ]. The pathogenesis of the CNS disease is uncertain. Possibilities include direct infection and an immune-mediated reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In cases of CNS involvement caused by",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    , a history of an antecedent respiratory illness usually, but not always, is found. In one retrospective review of cases at the Mayo Clinic, for example, 7 percent of patients with",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    pneumonia had CNS involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although uncommon, CNS involvement is associated with significant morbidity and mortality. One study evaluated 61 individuals with neurologic disease attributed to",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    and found that five (8 percent) patients died and 14 (23 percent) had severe sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal symptoms range from nonspecific (common) to those of pancreatitis (rare); the latter disorder may be due in part to antibodies to",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rheumatologic symptoms, including tender joints and muscles and a polyarthritis, can occur. Although arthralgias are common, actual arthritis is rare. Arthritis is believed to result from immune-mediated mechanisms; however,",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    has been isolated from synovial fluid in some patients with polyarthritis, suggesting a possible role for direct infection.",
"   </p>",
"   <p>",
"    Cardiac and renal involvement is unusual [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/5\">",
"     5",
"    </a>",
"    ]. Cardiac manifestations include rhythm disturbances, heart failure, chest pain, and conduction abnormalities on the electrocardiogram. Myocarditis rarely has been described in autopsy reports because the disease usually is not fatal. Clinically significant glomerulonephritis is a rare complication that is presumed to be secondary to immune complex deposition. In one case report, the glomerular disease correlated with high titer cold agglutinins, and the patient developed chronic renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/26\">",
"     26",
"    </a>",
"    ]. However, a cause-and-effect relationship was not proven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Radiographic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The findings on chest radiography vary considerably in patients with",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    pneumonia and may be difficult to appreciate; high-resolution computed tomography (CT) usually demonstrates abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    involving the lung results in four frequently described chest radiograph patterns:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bronchopneumonia",
"     </li>",
"     <li>",
"      Plate-like atelectasis",
"     </li>",
"     <li>",
"      Nodular infiltration",
"     </li>",
"     <li>",
"      Hilar adenopathy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common radiographic finding is the peribronchial pneumonia pattern, which consists of a thickened bronchial shadow, streaks of interstitial infiltration (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef86363 \" href=\"UTD.htm?1/6/1121\">",
"     image 1",
"    </a>",
"    ), and areas of atelectasis; these changes have a predilection for the lower lobes. Hilar adenopathy was noted in 34 percent of children in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/28\">",
"     28",
"    </a>",
"    ]. The finding of hilar adenopathy in children with suspected",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection should broaden the differential diagnosis to include tuberculosis.",
"   </p>",
"   <p>",
"    Pleural effusions can be seen in as many as 20 percent of patients when lateral decubitus films are performed [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/12\">",
"     12",
"    </a>",
"    ]. Empyema is a rare complication of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    pneumonia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/34/9770?source=see_link\">",
"     \"Epidemiology; clinical presentation; and evaluation of parapneumonic effusion and empyema in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27882?source=see_link\">",
"     \"Management and prognosis of parapneumonic effusion and empyema in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    High-resolution CT (HRCT) scan is more sensitive for demonstrating abnormalities than is chest radiography in cases of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    pneumonia. In one study of 28 patients with documented",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection who underwent both studies, air-space opacification was visible on chest radiography in 86 percent but was usually nonsegmental [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/27\">",
"     27",
"    </a>",
"    ]. By contrast, nodules and thickening of bronchovascular bundles were common HRCT findings (89 and 82 percent, respectively) and significantly less frequent findings on chest radiograph (50 and 18 percent, respectively).",
"   </p>",
"   <p>",
"    Late structural abnormalities also can be identified on HRCT; a series of 38 children who had been hospitalized with",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    pneumonia were scanned one to two years later and compared to 17 children who had not required hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/29\">",
"     29",
"    </a>",
"    ]. The hospitalized children had more frequent abnormal scans (37 versus 12 percent), including bronchiectasis in 21 percent. These findings were more common in younger children and those with higher antibody titers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Laboratory features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subclinical evidence of hemolytic anemia is present in most patients with pneumonia, as suggested by a positive Coombs test and an elevated reticulocyte count. Cold agglutinin titers are elevated in 50 percent of adult patients with mycoplasma disease, and the titer usually exceeds 1:128 in patients with pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/30\">",
"     30",
"    </a>",
"    ]. Less well studied in children, the accuracy of the cold agglutinin test in detecting upper respiratory infection caused by",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    is not known, and specificity is low if the titer is less than 1:64 because a variety of other respiratory pathogens may induce an increase in cold agglutinins.",
"   </p>",
"   <p>",
"    The peripheral white blood cell count (WBC) is normal or slightly elevated with neutrophilia. Thrombocytosis can occur and probably represents an acute phase response. Reported erythrocyte sedimentation rates range from 20 to more than 100",
"    <span class=\"nowrap\">",
"     mm/hr,",
"    </span>",
"    with higher rates suggestive of more severe pulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with neurologic involvement, the cerebrospinal fluid (CSF) typically reveals a lymphocytic pleocytosis, elevated protein, and normal glucose. Isolation of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    in the CSF is possible but rare [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/6,19\">",
"     6,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H101019976\">",
"    <span class=\"h2\">",
"     Clinical suspicion",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no distinguishing clinical or radiologic manifestations that allow a secure diagnosis of mycoplasma pneumonia versus chlamydial or viral pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/10\">",
"     10",
"    </a>",
"    ]. Compared to those with pyogenic pneumonia, however, patients with mycoplasma pneumonia tend to have a more gradual onset of symptoms, less respiratory distress, and usually a normal white blood cell count. However, these findings are neither sufficiently sensitive nor specific to exclude other etiologies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/55/2938?source=see_link&amp;anchor=H14#H14\">",
"     \"Epidemiology, pathogenesis, and etiology of pneumonia in children\", section on 'Etiologic agents'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features and diagnosis of community-acquired pneumonia in children\", section on 'Clues to etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H101019906\">",
"    <span class=\"h2\">",
"     Approach to diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unfortunately, there are no diagnostic tests that allow the reliable, rapid diagnosis of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. No diagnostic tests have been cleared by the US Food and Drug Administration for the detection of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection. Commercially available tests in other countries have variable sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/34\">",
"     34",
"    </a>",
"    ], so the clinician must be cautious in interpreting results [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/33\">",
"     33",
"    </a>",
"    ]. Given these shortcomings, a high clinical suspicion is essential for early treatment of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection. The diagnosis is usually confirmed in retrospect.",
"   </p>",
"   <p>",
"    Serology is the mainstay of laboratory diagnosis, using enzyme immunoassay of paired acute and convalescent sera. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Serology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    When available, the polymerase chain reaction (PCR), which can be done rapidly and has a high specificity, may be helpful, especially when combined with serology or culture. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Polymerase chain reaction'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Most clinical laboratories do not attempt to culture",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    because culture requires two to three weeks and",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    is fastidious. (See",
"    <a class=\"local\" href=\"#H101020085\">",
"     'Gram stain and culture'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Other tests, such as cold agglutinins, can occasionally be used to support a clinical diagnosis when a rapid diagnosis must be made. (See",
"    <a class=\"local\" href=\"#H101020033\">",
"     'Cold agglutinins'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most widely used approach for serodiagnosis is the complement fixation (CF) test, which measures \"early\" IgM (predominantly) and IgG antibody (to a lesser extent) to",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    . A positive result is defined as [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/35\">",
"     35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A fourfold or greater increase in titer in paired sera",
"      <strong>",
"       OR",
"      </strong>",
"     </li>",
"     <li>",
"      A single titer of greater than or equal to 1:32",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Antibody titers rise seven to nine days after infection and peak at three to four weeks. A fourfold decline in titer also is diagnostic if late samples are obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The CF test is highly sensitive for the detection of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection. In one study, for example, the overall sensitivity of the CF test was 90 percent in culture-proven cases of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/26\">",
"     26",
"    </a>",
"    ]. By comparison, the culture method was only 64 percent sensitive when used in individuals with serologic evidence of infection.",
"   </p>",
"   <p>",
"    A major disadvantage of the CF test is that false positive results may occur, particularly during inflammatory reactions, such as neurologic syndromes, bacterial meningitis, and acute pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/26\">",
"     26",
"    </a>",
"    ]. Despite this limitation, the CF test is the one most commonly ordered in clinical practice and the one we recommend.",
"   </p>",
"   <p>",
"    Other, more specific serologic tests, including an ELISA, which examines levels of IgG and IgM to the P1 adhesin of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    , are available. Antibody tests through agglutination are available, but they appear less sensitive than are the CF and EIA [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/36\">",
"     36",
"    </a>",
"    ]. Although antibody tests provide evidence of infection, time is required to collect acute and convalescent serum. In addition, although a single elevated IgM may be used to diagnose infection, this measurement cannot be used until almost seven days into the illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct PCR detects genomic DNA and may be highly sensitive and specific for",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    in patients with respiratory tract infections [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/37-40\">",
"     37-40",
"    </a>",
"    ]. One study, for example, compared the sensitivity and specificity of PCR on throat swab specimens with serology obtained from both healthy and hospitalized adults [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/39\">",
"     39",
"    </a>",
"    ]. PCR had a sensitivity of 92 percent and a specificity of 98 percent, and it was found to detect more",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    than did serology. Although not yet readily available clinically, PCR shows considerable promise in the diagnosis of pathogens causing atypical pneumonia.",
"   </p>",
"   <p>",
"    PCR can be performed on respiratory specimens such as throat swabs, sputum samples, bronchoalveolar lavage fluid, and nasopharyngeal aspirates [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/41\">",
"     41",
"    </a>",
"    ]. PCR can also be done on cerebrospinal fluid, but it has a low diagnostic yield. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/10/36006?source=see_link&amp;anchor=H8#H8\">",
"     \"Molecular diagnosis of central nervous system infections\", section on 'Bacteria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H101020385\">",
"    <span class=\"h3\">",
"     Antigen detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antigen detection can be performed by antigen capture-enzyme immunoassay (Ag-EIA), which may detect",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      4",
"     </sup>",
"     cfu/mL",
"    </span>",
"    (a level which should be present in the majority of infections) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/42\">",
"     42",
"    </a>",
"    ]. One problem with Ag-EIA is that the ability to detect antigen may vary with the time of sampling; the test is most often positive within seven days of onset.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H101020085\">",
"    <span class=\"h3\">",
"     Gram stain and culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The isolation of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    on SP-4 medium is possible. However, culture requires two to three weeks and",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    is fastidious. As a result, most clinical laboratories do not attempt to culture it [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A positive sputum Gram stain and culture can establish the diagnosis of bacterial pneumonia. However, children younger than five years usually swallow sputum, so it is rarely available for examination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=see_link&amp;anchor=H23#H23\">",
"     \"Clinical features and diagnosis of community-acquired pneumonia in children\", section on 'Cultures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H101020033\">",
"    <span class=\"h3\">",
"     Cold agglutinins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The formation of cold agglutinins is a nonspecific early IgM reaction against the erythrocyte I antigen. We do not routinely suggest obtaining cold agglutinin antibody titers in children because the accuracy of this test in detecting",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    in children is not known [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/33\">",
"     33",
"    </a>",
"    ]. Nor do we recommend performing bedside cold agglutinins because bedside cold agglutinins are neither sensitive nor specific for",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of antimicrobial therapy for the treatment of upper respiratory tract symptoms caused by",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    have not been adequately studied in children [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/43\">",
"     43",
"    </a>",
"    ]. However, limited data in children suggest that a macrolide antibiotic or a",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/38/28262?source=see_link\">",
"     tetracycline",
"    </a>",
"    should be prescribed when a lower respiratory tract infection is likely to be caused by",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    . One study from France, for example, measured pulmonary function six months and one year after a documented mycoplasma infection; children who received macrolide antibiotics started more than 10 days after symptom onset were more likely to have abnormal lung diffusion capacity than those treated earlier (73 versus 30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recommended regimens include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/15/35056?source=see_link\">",
"     azithromycin",
"    </a>",
"    10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    in one dose on the first day and 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    in one dose for four days,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/37/30297?source=see_link\">",
"     clarithromycin",
"    </a>",
"    15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in two divided doses for 10 days, or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/11/38064?source=see_link\">",
"     erythromycin",
"    </a>",
"    30 to 40",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in four divided doses for 10 days [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/45\">",
"     45",
"    </a>",
"    ]. Azithromycin and clarithromycin have the advantages of less frequent dosing and fewer gastrointestinal disturbances.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/38/28262?source=see_link\">",
"     Tetracycline",
"    </a>",
"    20 to 50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in four divided doses (maximum daily dose 1 to 2 g) and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/54/12136?source=see_link\">",
"     doxycycline",
"    </a>",
"    2 to 4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in one or two divided doses (maximum daily dose 100 to 200 mg) for 10 days also are effective and may be used in children eight years of age or older [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The issue of macrolide resistance is increasing in importance.",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    resistant to macrolides has been reported in Asia, France, Italy, Israel, and the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/47-52\">",
"     47-52",
"    </a>",
"    ]. Prolonged fevers may occur in children with macrolide-resistant isolates who are treated with macrolide antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/50,53\">",
"     50,53",
"    </a>",
"    ]. The possibility of macrolide resistance should be considered in children with suspected",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    infection who do not respond as expected to macrolide therapy.",
"   </p>",
"   <p>",
"    Tetracyclines (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/54/12136?source=see_link\">",
"     doxycycline",
"    </a>",
"    2 to 4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in one or two divided doses [maximum daily dose 100 to 200 mg] for 10 days) and fluoroquinolones (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/11/33968?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ) are alternative treatments for macrolide-resistant strains [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/52,54\">",
"     52,54",
"    </a>",
"    ]. Fluoroquinolones should only be used in children younger than 18 years if the benefits of therapy exceed the risks. Information regarding levofloxacin dose in children is limited. Some centers recommend 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 12 hours for 10 days for infants &ge;6 months and children &lt;5 years, and 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 24 hours for 10 days for children &ge;5 years, with a maximum daily dose of 500 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No studies have been performed that evaluate the effectiveness of alternative therapies in patients with hemolytic anemia or CNS involvement. Antibiotics would not be expected to have a major therapeutic role in this setting because these disorders are thought to arise from immune-mediated mechanisms, presumably at a time when antibodies to the organism have already been made by the host.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For hemolytic anemia, case reports indicate some patients respond to warming, steroid therapy, and possibly plasmapheresis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/4\">",
"       4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      For CNS disease, therapy with steroids, antiinflammatory drugs, diuretics, and plasma exchange have been used in addition to antibiotics without clear indication of benefit from any of these modalities [",
"      <a class=\"abstract\" href=\"UTD.htm?6/35/6713/abstract/5\">",
"       5",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/17/14611?source=see_link\">",
"       \"Patient information: Pneumonia in children (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/44/14019?source=see_link\">",
"       \"Patient information: Mycoplasma pneumonia in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <em>",
"       Mycoplasma pneumoniae",
"      </em>",
"      accounts for approximately 20 percent of acute pneumonias in middle and high school students and up to 50 percent of cases in college students and military recruits. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The signs and symptoms of",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      infection vary according to the stage of illness (",
"      <a class=\"graphic graphic_figure graphicRef59329 \" href=\"UTD.htm?41/0/41986\">",
"       figure 1",
"      </a>",
"      ). Extrapulmonary manifestations may include hemolysis, rash, musculoskeletal pain, and central nervous system, gastrointestinal, or cardiac involvement. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plain radiograph findings include bronchopneumonia, plate-like atelectasis, nodular infiltration, hilar adenopathy, and pleural effusions. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Radiographic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory features of",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      infection may include positive Coombs test, elevated reticulocyte count, elevated cold agglutinin titers, normal or slightly elevated white blood cell count, thrombocytosis, and elevation of the erythrocyte sedimentation rate. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Laboratory features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Compared to children with bacterial pneumonia, those with mycoplasma pneumonia tend to have a more gradual onset of symptoms, less respiratory distress, and a normal white blood cell count. However, these findings are neither sufficiently sensitive nor specific to exclude other etiologies (eg, chlamydia or viral pneumonia). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific diagnosis of",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      relies upon nonculture techniques, including serology (complement fixation test, ELISA) and antigen detection. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that children with",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      lower respiratory tract infection be treated with antimicrobial therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Alternative regimens include (see",
"      <a class=\"local\" href=\"#H21\">",
"       'Treatment'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/15/35056?source=see_link\">",
"       Azithromycin",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      in one dose on the first day and 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      in one dose for four days",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/37/30297?source=see_link\">",
"       Clarithromycin",
"      </a>",
"      15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in two divided doses for 10 days",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/11/38064?source=see_link\">",
"       Erythromycin",
"      </a>",
"      30 to 40",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in four divided doses for 10 days",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/38/28262?source=see_link\">",
"       Tetracycline",
"      </a>",
"      20 to 50",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in four divided doses for 10 days (maximum daily dose 1 to 2 g) or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/54/12136?source=see_link\">",
"       doxycycline",
"      </a>",
"      2 to 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in one or two divided doses for 10 days (maximum daily dose 100 to 200 mg) may be used in children eight years of age or older",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/54/12136?source=see_link\">",
"       Doxycycline",
"      </a>",
"      or a fluoroquinolone antibiotic should be used if macrolide-resistance is suspected or documented, particularly if the child is severely ill",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/1\">",
"      Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis 1996; 23:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/2\">",
"      Baseman JB, Tully JG. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 1997; 3:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/3\">",
"      Feizi T, Loveless RW. Carbohydrate recognition by Mycoplasma pneumoniae and pathologic consequences. Am J Respir Crit Care Med 1996; 154:S133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/4\">",
"      Baseman JB, Reddy SP, Dallo SF. Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections. Am J Respir Crit Care Med 1996; 154:S137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/5\">",
"      Martin RE, Bates JH. Atypical pneumonia. Infect Dis Clin North Am 1991; 5:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/6\">",
"      Luby JP. Pneumonia caused by Mycoplasma pneumoniae infection. Clin Chest Med 1991; 12:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/7\">",
"      Clyde WA Jr. Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis 1993; 17 Suppl 1:S32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/8\">",
"      Mogabgab WJ. Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966. Am Rev Respir Dis 1968; 97:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/9\">",
"      Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979; 139:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/10\">",
"      Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis 2001; 1:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/11\">",
"      Wang K, Gill P, Perera R, et al. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev 2012; 10:CD009175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/12\">",
"      Mansel JK, Rosenow EC 3rd, Smith TF, Martin JW Jr. Mycoplasma pneumoniae pneumonia. Chest 1989; 95:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/13\">",
"      Kotikoski MJ, Kleemola M, Palmu AA. No evidence of Mycoplasma pneumoniae in acute myringitis. Pediatr Infect Dis J 2004; 23:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/14\">",
"      Martin RJ, Chu HW, Honour JM, Harbeck RJ. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001; 24:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/15\">",
"      Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004; 38:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/16\">",
"      Atkinson TP, Duffy LB, Pendley D, et al. Deficient immune response to Mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc 2009; 30:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/17\">",
"      Cherry JD. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis 1993; 17 Suppl 1:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/18\">",
"      Pemira SM, Tolan RW Jr. Mycoplasma pneumoniae infection presenting as bullous papular purpuric gloves and socks syndrome: novel association and review of the literature. Clin Pediatr (Phila) 2011; 50:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/19\">",
"      Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis 1993; 17 Suppl 1:S52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/20\">",
"      Smith R, Eviatar L. Neurologic manifestations of Mycoplasma pneumoniae infections: diverse spectrum of diseases. A report of six cases and review of the literature. Clin Pediatr (Phila) 2000; 39:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/21\">",
"      Candler PM, Dale RC. Three cases of central nervous system complications associated with Mycoplasma pneumoniae. Pediatr Neurol 2004; 31:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/22\">",
"      Christie LJ, Honarmand S, Talkington DF, et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 2007; 120:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/23\">",
"      Walter ND, Grant GB, Bandy U, et al. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis 2008; 198:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/24\">",
"      Weng WC, Peng SS, Wang SB, et al. Mycoplasma pneumoniae--associated transverse myelitis and rhabdomyolysis. Pediatr Neurol 2009; 40:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/25\">",
"      Lin JJ, Hsia SH, Wu CT, et al. Mycoplasma pneumoniae-related postencephalitic epilepsy in children. Epilepsia 2011; 52:1979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/26\">",
"      Kenny GE, Kaiser GG, Cooney MK, Foy HM. Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections. J Clin Microbiol 1990; 28:2087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/27\">",
"      Reittner P, M&uuml;ller NL, Heyneman L, et al. Mycoplasma pneumoniae pneumonia: radiographic and high-resolution CT features in 28 patients. AJR Am J Roentgenol 2000; 174:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/28\">",
"      Niitu Y. M. pneumoniae respiratory diseases: clinical features--children. Yale J Biol Med 1983; 56:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/29\">",
"      Kim CK, Chung CY, Kim JS, et al. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics 2000; 105:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/30\">",
"      Tay YK, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol 1996; 35:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/31\">",
"      Nagayama Y, Sakurai N, Yamamoto K. Clinical observations of children with pleuropneumonia due to Mycoplasma pneumoniae. Pediatr Pulmonol 1990; 8:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/32\">",
"      Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 2009; 48:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/33\">",
"      Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53:e25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/34\">",
"      Touati A, Benard A, Hassen AB, et al. Evaluation of five commercial real-time PCR assays for detection of Mycoplasma pneumoniae in respiratory tract specimens. J Clin Microbiol 2009; 47:2269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/35\">",
"      Jacobs E. Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin Infect Dis 1993; 17 Suppl 1:S79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/36\">",
"      Thacker WL, Talkington DF. Comparison of two rapid commercial tests with complement fixation for serologic diagnosis of Mycoplasma pneumoniae infections. J Clin Microbiol 1995; 33:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/37\">",
"      Tjhie JH, van Kuppeveld FJ, Roosendaal R, et al. Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections. J Clin Microbiol 1994; 32:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/38\">",
"      Blackmore TK, Reznikov M, Gordon DL. Clinical utility of the polymerase chain reaction to diagnose Mycoplasma pneumoniae infection. Pathology 1995; 27:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/39\">",
"      Ramirez JA, Ahkee S, Tolentino A, et al. Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. Diagn Microbiol Infect Dis 1996; 24:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/40\">",
"      Xu D, Li S, Chen Z, Du L. Detection of Mycoplasma pneumoniae in different respiratory specimens. Eur J Pediatr 2011; 170:851.",
"     </a>",
"    </li>",
"    <li>",
"     Baum SG. Mycoplasma pneumoniae and atypical pneumonia. In: Principles and Practice of Infectious Diseases, 7th Ed, Mandell GL, Bennett JE, Dolin R.  (Eds), Churchill Livingstone, Philadelphia 2010. p.2481.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/42\">",
"      Marmion BP, Williamson J, Worswick DA, et al. Experience with newer techniques for the laboratory detection of Mycoplasma pneumoniae infection: Adelaide, 1978-1992. Clin Infect Dis 1993; 17 Suppl 1:S90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/43\">",
"      Mulholland S, Gavranich JB, Gillies MB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev 2012; 9:CD004875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/44\">",
"      Marc E, Chaussain M, Moulin F, et al. Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia. Pediatr Infect Dis J 2000; 19:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/45\">",
"      Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995; 14:471.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Mycoplasma pneumoniae and other Mycoplasma species infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.518.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/47\">",
"      Peuchant O, M&eacute;nard A, Renaudin H, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 2009; 64:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/48\">",
"      Averbuch D, Hidalgo-Grass C, Moses AE, et al. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis 2011; 17:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/49\">",
"      Yamada M, Buller R, Bledsoe S, Storch GA. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J 2012; 31:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/50\">",
"      Kawai Y, Miyashita N, Yamaguchi T, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Respirology 2012; 17:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/51\">",
"      Chironna M, Sallustio A, Esposito S, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother 2011; 66:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/52\">",
"      Okada T, Morozumi M, Tajima T, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis 2012; 55:1642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/53\">",
"      Yoo SJ, Kim HB, Choi SH, et al. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance. Antimicrob Agents Chemother 2012; 56:6393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/54\">",
"      B&eacute;b&eacute;ar C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol 2011; 6:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/35/6713/abstract/55\">",
"      Chien S, Wells TG, Blumer JL, et al. Levofloxacin pharmacokinetics in children. J Clin Pharmacol 2005; 45:153.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6070 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-B60670ABF6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6713=[""].join("\n");
var outline_f6_35_6713=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Respiratory tract disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Possible relation to asthma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Extrapulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Hemolysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Skin disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - CNS involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Radiographic features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Laboratory features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H101019976\">",
"      Clinical suspicion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H101019906\">",
"      Approach to diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Serology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H101020385\">",
"      - Antigen detection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H101020085\">",
"      - Gram stain and culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H101020033\">",
"      - Cold agglutinins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6070\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6070|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/6/1121\" title=\"diagnostic image 1\">",
"      M pneumoniae radiograph",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6070|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/0/41986\" title=\"figure 1\">",
"      Clinical findings M pneumoniae",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30424?source=related_link\">",
"      Approach to wheezing in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=related_link\">",
"      Clinical features and diagnosis of community-acquired pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=related_link\">",
"      Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/55/2938?source=related_link\">",
"      Epidemiology, pathogenesis, and etiology of pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/34/9770?source=related_link\">",
"      Epidemiology; clinical presentation; and evaluation of parapneumonic effusion and empyema in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27882?source=related_link\">",
"      Management and prognosis of parapneumonic effusion and empyema in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/10/36006?source=related_link\">",
"      Molecular diagnosis of central nervous system infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/28/31177?source=related_link\">",
"      Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3162?source=related_link\">",
"      Mycoplasma pneumoniae infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30535?source=related_link\">",
"      Pathogenesis of autoimmune hemolytic anemia: Cold agglutinin disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/44/14019?source=related_link\">",
"      Patient information: Mycoplasma pneumonia in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/17/14611?source=related_link\">",
"      Patient information: Pneumonia in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/41/1689?source=related_link\">",
"      Wheezing illnesses other than asthma in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_35_6714="Assessment of optic disc A";
var content_f6_35_6714=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50075%7EPC%2F65935&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50075%7EPC%2F65935&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Assessment of the optic disc in healthy and glaucomatous eyes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 406px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A: Optic nerve photography: small central cup in healthy eye; enlarged cup and loss of inferotemporal neuroretinal rim in glaucomatous eye; B: Retinal nerve fibre layer photography: uniform reflections in healthy eye; poor reflections in inferotemporal region (arrows) in glaucomatous eye. Reprinted with permission",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     from: Weinreb, RN, Khaw, PT. Primary open-angle glaucoma. Lancet 2004; 363:1711. Copyright &copy; 2004 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 547px\">",
"   <div class=\"ttl\">",
"    Assessment of the optic disc in healthy and glaucomatous eyes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 527px; height: 386px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The top row shows findings in normal eyes and the bottow row findings in glaucomatous eyes. C: Scanning laser polarimetry: retinal nerve fibre layer thickness is reduced inferotemporally and superonasally. D: Confocal scanning laser ophthalmoscopy: neuroretinal rim area is within normal limits (ticks) in healthy eye but reduced in inferior and superonasal regions (crosses) in glaucomatous eye. E: Standard automated perimetry: normal blind spot and superior scotomas (arrows) in glaucoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from: Weinreb, RN, Khaw, PT. Primary open- angle glaucoma. Lancet 2004; 363:1711. Copyright &copy; 2004 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6714=[""].join("\n");
var outline_f6_35_6714=null;
var title_f6_35_6715="Manifestations of adult Stills";
var content_f6_35_6715=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F79051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F79051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of adult stills disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Evanescent rash",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arthritis/arthralgias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe myalgias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphadenopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Splenomegally",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute pharyngitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pleuritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pericarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mild alopecia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6715=[""].join("\n");
var outline_f6_35_6715=null;
var title_f6_35_6716="BAV AS adolescents young adults";
var content_f6_35_6716=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51270&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51270&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Balloon aortic valvotomy (BAV) for aortic stenosis (AS) in adolescents and young adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       BAV is indicated in the following settings is this population:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; With symptoms of angina, syncope, or dyspnea on exertion and catheterization peak left ventricular (LV)-to-peak aortic gradient greater than or equal to 50 mmHg* in the absence of a heavily calcified valve.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; For asymptomatic individuals with catheterization peak LV-to-peak aortic gradient &gt;60 mmHg*.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; For asymptomatic individuals with ST or T wave changes over the left precordium on the electrocardiogram (ECG) at rest or with exercise and a peak LV-to-peak aortic gradient &gt;50 mmHg*.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       BAV is reasonable in the following settings in this population:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Asymptomatic individuals who want to play competitive sports or become pregnant who have a catheterization peak LV-to-peak aortic gradient &gt;50 mmHg*.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; BAV is probably recommended over valve surgery if BAV is possible. Such patients should be referred to a center with expertise with BAV.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       BAV should NOT be performed in the following setting in this population:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Asymptomatic individuals who, have a catheterization peak LV-to-peak aortic gradient &lt;40 mmHg without symptoms or ECG changes.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The peak LV-to-peak aortic gradients are generally obtained with the patient sedated. The gradients may be somewhat lower if general anesthesia is used.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6716=[""].join("\n");
var outline_f6_35_6716=null;
var title_f6_35_6717="HCW infections after stick";
var content_f6_35_6717=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69942&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69942&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Documented occupational infections following exposure to blood or body fluids in healthcare workers or laboratory personnel",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tr>",
"          <td class=\"subtitle1_single\">",
"           Viral infections",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Bolivian viral hemorrhagic fever (needlestick, nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Crimean Congo viral hemorrhagic fever (nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Dengue (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Ebola viral hemorrhagic fever (nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Hepatitis B virus (needlestick, nonintact skin, mucous membranes)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Hepatitis C virus (needlestick, nonintact skin, mucous membranes)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Hepatitis D virus (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Hepatitis G virus (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Herpes simplex 1 (needlestick, nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Human immunodeficiency virus 1 (needlestick, nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Lassa viral hemorrhagic fever (nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Marburg viral hemorrhagic fever (needlestick, nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Varicella zoster virus (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Yellow fever virus (nonintact skin)",
"          </td>",
"         </tr>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tr>",
"          <td class=\"subtitle1_single\">",
"           Bacterial and rickettsial infections",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Corynebacterium diphtheriae (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Corynebacterium striatum (scalpel cut)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Mycobacterium leprae (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Mycobacterium marinum (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Mycobacterium tuberculosis (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Rickettsia rickettsii (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Staphylococcus aureus (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Streptococcus pyogenes (scapel cut)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Streptococcus pyogenes {necrotizing fasciitis}(nonintact skin)",
"          </td>",
"         </tr>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tr>",
"          <td class=\"subtitle1_single\">",
"           Fungal and parasitic infections",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Blastomyces dermatitidis (scalpel cut)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Cryptococcus neoformans (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Leishmania sp. (needlestick, nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Plasmodium falciparum (nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Plasmodium malariae (needlestick, nonintact skin)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Plasmodium vivax (needlestick)",
"          </td>",
"         </tr>",
"         <tr>",
"          <td>",
"           Trypanosoma brucei (needlestick)",
"          </td>",
"         </tr>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Tarantola, A, Abiteboul, D, Rachline, A. Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases. Am J Infect Control 2006; 34:367.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6717=[""].join("\n");
var outline_f6_35_6717=null;
var title_f6_35_6718="Contents: Rhinitis and sinusitis";
var content_f6_35_6718=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?43/1/44061\">",
"       Allergy and Immunology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Rhinitis and sinusitis",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Rhinitis and sinusitis",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Allergic rhinitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/53/22362\">",
"           Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/50/6953\">",
"           Complementary and alternative therapies for allergic rhinitis and conjunctivitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/17/27925\">",
"           Immunologic treatments for allergic rhinitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/39/6775\">",
"           Pathogenesis of allergic rhinitis (rhinosinusitis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/60/37834\">",
"           Pharmacotherapy of allergic rhinitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/34/1578\">",
"           Sublingual and oral immunotherapy for allergic rhinitis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         ENT disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/30/13801\">",
"           Anatomy and etiology of taste and smell disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/1/18455\">",
"           Evaluation and treatment of taste and smell disorders",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other forms of rhinitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/17/30999\">",
"           An overview of rhinitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/5/18519\">",
"           Atrophic rhinosinusitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/61/12250\">",
"           Chronic nonallergic rhinitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/44/16072\">",
"           Etiologies of nasal symptoms: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/48/7945\">",
"           Occupational rhinitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/18/20776\">",
"           Relationships between rhinosinusitis and asthma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sinusitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/48/39688\">",
"           Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/15/2297\">",
"           Acute sinusitis and rhinosinusitis in adults: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/34/35370\">",
"           Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/36/8775\">",
"           Fungal rhinosinusitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/4/30794\">",
"           Management of chronic rhinosinusitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/46/6890\">",
"           Mucormycosis (zygomycosis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/25/11674\">",
"           Orbital cellulitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/38/23145\">",
"           Septic dural sinus thrombosis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-A5B1F9AC7E-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f6_35_6718=[""].join("\n");
var outline_f6_35_6718=null;
var title_f6_35_6719="Dysostosis skull radiograph";
var content_f6_35_6719=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dysostosis skull radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dysostosis multiplex seen on a lateral skull radiograph with expansion of sella turcica.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ed Wraith, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_35_6719=[""].join("\n");
var outline_f6_35_6719=null;
